DATAWIZARD SRL

Their core work

DataWizard is a Rome-based technology SME specializing in digital health solutions, particularly around medication information systems, drug data standardization, and patient-facing health tools. They build software platforms that help patients manage medications, support pharmacovigilance processes, and enable cross-border eHealth data exchange. Their technical capabilities span data integration, federated learning, affective computing, and personalized digital health services.

What they specialise in

How they've shifted over time

DataWizard began with broader digital health and wellness topics — personalized nutrition, physical activity, NCD prevention (PROTEIN, 2018), and affective computing for care environments (TeNDER, 2019). From 2019 onward, they shifted decisively toward pharmaceutical data infrastructure: drug identification standards (IDMP), cross-border eHealth interoperability, pharmacovigilance, and patient medication management. Their most recent projects (Gravitate-Health, GenoMed4ALL) show a deepening focus on structured health data, AI-driven analysis, and regulatory-grade information systems.

DataWizard is converging on pharmaceutical informatics and medication data platforms — expect future work in drug safety, patient health literacy tools, and EU-wide health data space initiatives.

How they like to work

DataWizard primarily operates as a participant (5 of 6 projects), joining large consortia rather than leading them. With 136 unique partners across 24 countries, they are a broadly connected SME that integrates into diverse teams rather than anchoring around a fixed set of collaborators. Their single coordination (PW) was also their largest grant, suggesting they can lead when the topic aligns closely with their core product.

DataWizard has collaborated with 136 unique partners across 24 countries, indicating a wide European network well beyond Italy. Their projects span health agencies, universities, pharma-adjacent organizations, and technology providers across the EU.

What sets them apart

DataWizard occupies a distinctive niche at the intersection of pharmaceutical data standards and patient-facing digital tools — they understand both the regulatory/technical side (IDMP, EMA standards, pharmacovigilance) and the user experience side (medication awareness, self-management). This dual capability is rare among SMEs, making them a valuable partner for projects that need to translate complex drug data into accessible citizen services. Their consistent involvement in medication-related projects since 2015 gives them domain depth that generalist IT companies lack.

Highlights from their portfolio

• PW
  Their only coordinated project and largest single grant (EUR 1.96M) — a medication awareness platform that likely represents their core product/service.
• UNICOM
  Major EU-wide initiative to standardize global drug identification (IDMP), involving EMA and cross-border eHealth networks — positions DataWizard in regulatory health informatics.
• GenoMed4ALL
  Applies federated learning and multi-omics to haematological diseases, showing DataWizard's expansion into AI-driven genomic medicine beyond their pharmaceutical data roots.